PLUS1
347.71
10.51 (3.12%)
10.51 (3.12%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Bio Techne Corporation | TECH | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 10.51 | 3.12% | 347.71 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 340.92 | 337.20 | 349.46 | 347.71 | 337.20 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 229.68 | 350.00 | 120.32 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 5,657 | 307,192 | $ 344.43 | $ 105,807,237 | 159,951 | 155.17 - 349.46 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:11:05 | 5 | $ 348.10 | USD |
Bio Techne Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 13.42B | 38.61M | 34.50M | $ 738.69M | $ 165.39M | 5.80 | 52.80 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ 1.28 | 0.37% | 8.85k | 3.90% |
Bio Techne News
| Date | Time | Source | News Article |
|---|---|---|---|
| 1/14/2021 | 07:00 | PR Newswire (US) | Bio-Techne To Host Conference Call On February 2, 2021 To.. |
| 1/13/2021 | 17:19 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 12/21/2020 | 07:00 | PR Newswire (US) | Bio-Techne To Present At The 39th Annual J.P. Morgan.. |
| 12/09/2020 | 16:28 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 12/02/2020 | 18:02 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 12/02/2020 | 07:00 | PR Newswire (US) | Regulus Therapeutics Collaborates With Bio-Techne For.. |
| 11/25/2020 | 07:30 | PR Newswire (US) | Kantaro Receives FDA Emergency Use Authorization for.. |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical TECH Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 337.41 | 349.46 | 325.24 | 333.03 | 140,213 | 10.30 | 3.05% |
| 1 Month | 309.26 | 349.46 | 307.87 | 324.03 | 170,671 | 38.45 | 12.43% |
| 3 Months | 270.98 | 349.46 | 250.24 | 304.65 | 163,487 | 76.73 | 28.32% |
| 6 Months | 267.19 | 349.46 | 228.665 | 279.25 | 158,677 | 80.52 | 30.14% |
| 1 Year | 218.13 | 349.46 | 155.17 | 245.50 | 201,551 | 129.58 | 59.4% |
| 3 Years | 140.13 | 349.46 | 128.06 | 202.08 | 186,802 | 207.58 | 148.13% |
| 5 Years | 81.93 | 349.46 | 79.95 | 167.12 | 178,587 | 265.78 | 324.4% |
Bio Techne Description
| Bio-Techne Corp is a life science manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences, and diagnostics and genomics. It generates maximum revenue from the protein sciences segment. The Protein Sciences Segment comprises two subdivisions namely Reagent Solutions and Analytical Solutions. Its Diagnostics and Genomics segment comprise two subdivisions Diagnostics Reagents and Genomics. Geographically, it derives a majority of revenue from the United States and also has a presence in EMEA; UK; APAC; Greater China, and Rest of world. |
